Home » Topics » Regulatory

Regulatory
RSS

Prozac approved for pediatric depression and OCD

Jan. 9, 2003

FDA approves Singulair for seasonal allergic rhinitis

Jan. 9, 2003

FDA approves Clozaril to reduce the risk of suicidal behavior

Jan. 9, 2003

Pfizer launches three-day antibiotic for middle ear infections

Jan. 9, 2003

Finacea approved for topical treatment of rosacea

Jan. 9, 2003

sNDA filed for Seroquel in acute mania associated with bipolar disorder

Jan. 8, 2003

Zovirax approved by FDA for recurrent cold sores

Jan. 8, 2003

Zyvox approved for bacterial infections in infants and children

Jan. 8, 2003

Endo submits NDA for extended-release oxymorphone

Jan. 8, 2003

Metformin XT NDA submitted for type 2 diabetes

Jan. 8, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...